- News & Features
Uncertainty around potential health insurance changes has the chronic disease community on edge.
Welcome Molly, our new CreakyJoints Blog Manager. As a patient with multiple chronic diseases, Molly will lend her insight, strength, and empathy to the CreakyJoints community.
This past year has had its ups and downs. Take a moment to read some of the perspectives that have been shared on the CreakyJoints website.
Get to know Shilpa Venkatachalam, our research associate.
The first head-to-head study comparing one tumor necrosis factor (TNF) inhibitor with another found similar outcomes for certolizumab pegol and adalimumab.
Preliminary findings link proton pump inhibitors (PPIs), drugs commonly used to reduce stomach acid and treat heartburn, to increased risk for ischemic stroke.
Researchers found that Rituximab was successful in treating a variety of autoimmune and immune-mediated cutaneous disorders.
A study found that the addition of voclosporin to standard treatment of acute lupus nephritis increased the speed of remission and overall remission rates.
As more people turn to the Internet for advice, we are reminded of the importance of being vigilant about where and how we get our information and support.
The book features more than 50 easy-to-follow recipes meant to help manage inflammation.